Latest News
Aspen Pharmacare Canada receives Health Canada approval for a generic equivalent of Ozempic®
New generic equivalent of Ozempic® expected to help expand access to semaglutide treatment options for adults with type 2 diabetes in Canada Oakville, ON — July 21, 2026 — Aspen Pharmacare Canada Inc., a subsidiary of Aspen Pharmacare Holdings Limited (“Aspen”), today announced that Health Canada has approved ᴾʳAspen-Semaglutide, a generic equivalent of Ozempic® (semaglutide
Important Safety Information on Importation of Danish-authorized Marcain–Adrenalin, 5 mg/mL and 5 mcg/mL due to the Current Shortage of Canadian-authorized SENSORCAINE with Epinephrine, 5 mg/mL and 5 mcg/mL
Important Safety Information on Importation of Danish-authorized Marcain–Adrenalin, 5 mg/mL and 5 mcg/mL due to the Current Shortage of Canadian-authorized SENSORCAINE with Epinephrine, 5 mg/mL and 5 mcg/mL
ASPEN PHARMACARE CANADA Inc. Launches ASPEN-Dienogest for the Management of Pelvic Pain Associated With Endometriosis
Oakville, ON, April 15, 2020 – Aspen Pharmacare Canada Inc. is proud to launch ASPEN-Dienogest, a generic drug whose bioequivalence to the brand product VISANNE® has been demonstrated the management of pelvic pain associated with endometriosis. ASPEN-Dienogest provides the same efficacy and safety as the brand product, at a lower cost to patients. ASPEN-Dienogest is